Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$43.41

2.48 (6.06%)

07:44
07/24/17
07/24
07:44
07/24/17
07:44

Sarepta price target raised to $73 from $65 at Janney Capital

Janney Capital analyst Debjit Chattopadhyay raised his fair value estimate on Sarepta to $73 from $65 after noting that the company's Q2 results and revised guidance show that the commercial launch of Exondys 51 is tracking significantly ahead of expectations. The phase 2 data from Golodirsen, which is most likely to come at the WMC meeting in October, could be the next big event for Sarepta, said Chattopadhyay, who keeps a Buy rating on the stock.

  • 25

    Jul

SRPT Sarepta
$43.41

2.48 (6.06%)

07/20/17
LEER
07/20/17
NO CHANGE
Target $60
LEER
Outperform
Sarepta price target raised to $60 from $52 at Leerink
Leerink analyst Joseph Schwartz raised his price target for Sarepta to $60 from $52 as "strong" Exondys51 sales in Q2 handily beat estimates leading to yet another revised 2017 guidance. The analyst reiterates an Outperform rating on the shares.
07/20/17
NEED
07/20/17
NO CHANGE
Target $75
NEED
Buy
Sarepta guidance still 'too conservative,' says Needham
Needham analyst Chad Messer notes that Sarepta reported Q2 Exondys revenues of $35M, significantly beating Street expectations, and again raised guidance for 2017 from above $95M to $125M-130M, a level he still views as conservative. The analyst now sees Sarepta achieving profitability as early as Q2 of 2018. He reiterates a Buy rating and $75 price target on the shares.
07/20/17
COWN
07/20/17
NO CHANGE
Target $69
COWN
Outperform
Sarepta price target raised to $69 from $62 at Cowen
Cowen analyst Ritu Baral raised her price target on Sarepta to $69 from $62 following Q2 results. The analyst noted results were solid and the company raised its sales guidance for Exondys 51 and sees it on track for a first half 2018 EU decision. She sees longer-term value in the company's maturing pipeline with multiple readouts expected by year-end. Baral reiterated her Outperform rating on Sarepta shares.
07/20/17
RHCO
07/20/17
NO CHANGE
RHCO
Sarepta price target raised to $56 from $45 at SunTrust
SunTrust analyst Edward Nash raised his price target on Sarepta (SRPT) after Sarepta and BioMarin (BMRN) executed a license agreement that provides Sarepta Therapeutics with global exclusive rights to BioMarin's DMD patent estate for EXONDYS 51 and all future exon-skipping products. The analyst says that EXONDYS 51 "continued to demonstrate strong momentum" in Q2, and he keeps a Buy rating on Sarepta.

TODAY'S FREE FLY STORIES

DRI

Darden

$86.55

0.14 (0.16%)

09:05
12/12/17
12/12
09:05
12/12/17
09:05
Recommendations
Darden analyst commentary  »

Darden price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 08

    Jan

MAT

Mattel

$15.37

0.33 (2.19%)

09:05
12/12/17
12/12
09:05
12/12/17
09:05
Technical Analysis
Technical View: Mattel falls, levels to watch »

In pre-market trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCHX

Marchex

$3.19

0.01 (0.31%)

09:05
12/12/17
12/12
09:05
12/12/17
09:05
Hot Stocks
Marchex announces special 50c cash dividend for common stock »

Marchex announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTX

United Technologies

$123.30

0.49 (0.40%)

09:04
12/12/17
12/12
09:04
12/12/17
09:04
Hot Stocks
Pratt & Whitney signs 12-year EngineWise Fleet Management pact with S7 Airlines »

Pratt & Whitney, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INVH

Invitation Homes

$23.67

0.02 (0.08%)

09:04
12/12/17
12/12
09:04
12/12/17
09:04
Initiation
Invitation Homes initiated  »

Invitation Homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KR

Kroger

$26.58

-0.1 (-0.37%)

09:04
12/12/17
12/12
09:04
12/12/17
09:04
Hot Stocks
Kroger teams up with Chase Pay to offer mobile payments »

The Kroger is teaming up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

P

Pandora

$5.03

0.13 (2.65%)

, GPS

Gap

$33.60

0.11 (0.33%)

09:03
12/12/17
12/12
09:03
12/12/17
09:03
Hot Stocks
Pandora names Aimee Lapic as Chief Marketing Officer, effective December 13 »

Pandora (P) announced…

P

Pandora

$5.03

0.13 (2.65%)

GPS

Gap

$33.60

0.11 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

ALLY

Ally Financial

$28.77

0.12 (0.42%)

09:02
12/12/17
12/12
09:02
12/12/17
09:02
Hot Stocks
Ally Financial appoints Jenn LaClair as CFO designate »

Ally Financial announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

ACER

Acer Therapeutics

$14.15

-0.42 (-2.88%)

09:02
12/12/17
12/12
09:02
12/12/17
09:02
Syndicate
Acer Therapeutics 917K share Spot Secondary priced at $12.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

ACM

Aecom

$38.51

-0.06 (-0.16%)

09:02
12/12/17
12/12
09:02
12/12/17
09:02
Hot Stocks
Aecom raises five-year adjusted EPS growth forecast to 12%-15% »

AECOM will hold its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

OAS

Oasis Petroleum

09:00
12/12/17
12/12
09:00
12/12/17
09:00
Syndicate
Oasis Petroleum 32M share Spot Secondary priced at $9.55 »

The deal range was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

PRSC

Providence Service

$58.26

0.08 (0.14%)

09:00
12/12/17
12/12
09:00
12/12/17
09:00
Syndicate
Providence Service 320K share Block Trade priced at $56.75 »

Jefferies acted as sole…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

DXTR

Dextera Surgical

$0.14

-0.003 (-2.14%)

09:00
12/12/17
12/12
09:00
12/12/17
09:00
Hot Stocks
Breaking Hot Stocks news story on Dextera Surgical »

Dextera Surgical trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GKOS

Glaukos

$24.85

-1.11 (-4.28%)

08:59
12/12/17
12/12
08:59
12/12/17
08:59
Recommendations
Glaukos analyst commentary  »

Reimbursement remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLYC

GlycoMimetics

$14.32

-0.65 (-4.34%)

08:57
12/12/17
12/12
08:57
12/12/17
08:57
Recommendations
GlycoMimetics analyst commentary  »

GlycoMimetics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

08:56
12/12/17
12/12
08:56
12/12/17
08:56
General news
Redbook Store Sales data reported »

Week of 12/9 Redbook…

BAC

Bank of America

$28.94

-0.11 (-0.38%)

, T

AT&T

$36.90

0.17 (0.46%)

08:55
12/12/17
12/12
08:55
12/12/17
08:55
Options
Notable open interest changes for December 12th »

Monday's total…

BAC

Bank of America

$28.94

-0.11 (-0.38%)

T

AT&T

$36.90

0.17 (0.46%)

AAPL

Apple

$172.67

3.3 (1.95%)

MU

Micron

$43.01

-0.2 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 09

    Jan

08:55
12/12/17
12/12
08:55
12/12/17
08:55
General news
Treasury Action: yields extended their rise »

Treasury Action: yields…

HI

Hillenbrand

$45.10

-0.45 (-0.99%)

08:55
12/12/17
12/12
08:55
12/12/17
08:55
Conference/Events
Hillenbrand to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

ARGX

Argenx

$54.47

24.02 (78.88%)

08:54
12/12/17
12/12
08:54
12/12/17
08:54
Technical Analysis
Technical View: Argenx falls after filing to sell $150M in ADSs »

In premarket trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

URBN

Urban Outfitters

$32.27

-0.82 (-2.48%)

08:53
12/12/17
12/12
08:53
12/12/17
08:53
Recommendations
Urban Outfitters analyst commentary  »

Urban Outfitters price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jan

H

Hyatt

$71.90

-0.39 (-0.54%)

08:53
12/12/17
12/12
08:53
12/12/17
08:53
Syndicate
Hyatt 2.7M share Block Trade priced at $71.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

  • 12

    Dec

AGN

Allergan

$172.76

4.96 (2.96%)

08:53
12/12/17
12/12
08:53
12/12/17
08:53
Hot Stocks
Allergan receives FDA clearance for CoolSculpting treatment »

Allergan announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Mar

GRMN

Garmin

$61.96

-0.31 (-0.50%)

08:52
12/12/17
12/12
08:52
12/12/17
08:52
Recommendations
Garmin analyst commentary  »

Garmin price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:50
12/12/17
12/12
08:50
12/12/17
08:50
General news
FX Action: The dollar »

FX Action: The dollar…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.